These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22815381)

  • 1. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.
    Leval A; Herweijer E; Arnheim-Dahlström L; Walum H; Frans E; Sparén P; Simard JF
    J Infect Dis; 2012 Sep; 206(6):860-6. PubMed ID: 22815381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.
    Read TR; Hocking JS; Chen MY; Donovan B; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2011 Dec; 87(7):544-7. PubMed ID: 21970896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
    Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
    Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine.
    Nsouli-Maktabi H; Ludwig SL; Yerubandi UD; Gaydos JC
    MSMR; 2013 Feb; 20(2):17-20. PubMed ID: 23461306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
    Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
    J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
    Yancey AM; Pitlick JM; Forinash AB
    Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
    Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
    J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
    Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
    Sandø N; Kofoed K; Zachariae C; Fouchard J
    Acta Derm Venereol; 2014 May; 94(3):288-92. PubMed ID: 24150529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-vaccination incidence of genital warts in 15-23-year-old women and men attending youth clinics in Stockholm, Sweden.
    Wikström A; Brönnegård M; Cassel T; Young C
    Scand J Infect Dis; 2012 Sep; 44(9):678-82. PubMed ID: 22568687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.
    Blomberg M; Dehlendorff C; Sand C; Kjaer SK
    Clin Infect Dis; 2015 Sep; 61(5):676-82. PubMed ID: 25944340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E; Ploner A; Sparén P
    Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.